Leading Regeneration from Geistlich Biomaterials

e-gen NEWS

Geistlich Biomaterials

Home E-Shop Events Contact Facebookinstagramlinked in issue

Clinical Case

Randomized Controlled Clinical Study Evaluating Effectiveness and Safety of a Volume-Stable Collagen Matrix Compared to Autogenous Connective Tissue Grafts for Soft-Tissue Augmentation at Implant Sites

Thoma DS, Zeltner M, Hilbe M, Hämmerle CHF, Hüsler J, Jung RE

Geistlich Fibro-Gide®:The alternative soft-tissue graft reveals the softer side of Geistlich innovation supported by hard facts. In the first multi-patient study utilizing Geistlich Fibro-Gide®, clinicians investigate and determine the safety and comparability of the volume-stable collagen matrix to the connective tissue graft.

› FULL RESULTS

Guidance By Geistlich

Now Available On Demand

Dr. David Lipton

Did you miss our latest educational webinar with Dr. David Lipton discussing the importance and potential benefits of soft-tissue augmentation around teeth and implants for practitioners and patients? You can find this and other past webinars archived on our online learning website.

› VIEW HERE

News You Can Use

Introducing Geistlich Fibro-Gide®

From concept to reality and a market need to your patients care, experience the milestones in the development of our latest innovation, Geistlich Fibro- Gide®. You can feel confident sharing with your patients why you chose the alternative soft-tissue graft.

› VIEW NOW

Upcoming Educational Events

"To Graft or Not to Graft"

Osteo Science Foundation
February 15 - 16, 2019
Hutton Hotel | Nashville, TN

› LEARN MORE

Osteology Barcelona

April 25-27, 2019
Barcelona International Convention Centre | Barcelona, Spain

› LEARN MORE

Featured Promotion

promotion

Only a few days left to take advantage of our Year-End Savings

› SHOP NOW

Customer Care Toll-free

855-799-5500

› EMAIL US

Share with your Colleagues

Copyright © 2018 Geistlich Pharma North America, Inc., All rights reserved. | GB-4017h-18E